Thereby, the trend is that the antibodies, only partly present prior to infection, bind to those glycan fractions with lower binding to DC-SIGN, MGL, and CRP but high recognition by the anti-FLDNF, anti-LDNF, and anti-PC (TEPC-15) monoclonal antibodies. The gene discussed is CD209; the disease is infection.